The fact they have 6 papers approved for presentation in front of 10,000 scientists/proffesionals involved in neurology....all on MS416 and its method(s) of action and preliminary results to date....is big news and will generate big interest......MS416's method of action is unique to previously tried anti-inflammatory methods,
Kind regards, SEAH.
Dr Robert Peach says......, page-9
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $42.59M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $8.402K | 52.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 97806 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 374091 | 4 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |